Silo Pharma, Inc.

SILO Nasdaq SEC CIK 1514183
Follow Silo Pharma Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0 −100% vs same quarter last year
Net income −$358.7K +67.7% vs same quarter last year
EPS, diluted −$0.21 +88.3% vs same quarter last year
Operating cash flow −$603.5K +36.8% vs same quarter last year
Revenue by quarter
$18K
$18K
$18K
$18K
$18K
$18K
$0
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$5M−$2.5M$0$2.5M$5MFY11FY13FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$72.1K−$4.2M
FY24$72.1K−$4.4M
FY23$72.1K−$3.7M
FY22$72.1K−$3.9M
FY21-$3.9M
FY20$40.9K−$3M
FY19$40.6K−$1M
FY18-−$969.5K
FY17-$356.5K
FY16--
FY13--
FY12-−$39.4K
FY11-−$49.8K
FY10--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%2000%FY11FY13FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2538.6%−5937%−5863.5%
FY2491.9%−6526.4%−6092.6%
FY2391.9%−5347.4%−5132.6%
FY2291.9%−5031.3%−5420.9%
FY21---
FY20−330.4%−5380.2%−7422.5%
FY1932.5%−2293.4%−2497.7%
FY18---
FY17---
FY16---
FY13---
FY12---
FY11---
FY10---
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Silo Pharma
  • Healthcare median
−8000%−6000%−4000%−2000%0%FY11FY13FY17FY19FY21FY23FY25
Show the numbers
YearSilo PharmaHealthcare median
FY25−5863.5%−30.6%
FY24−6092.6%−47%
FY23−5132.6%−58%
FY22−5420.9%−80.4%
FY21-−71.8%
FY20−7422.5%−62.2%
FY19−2497.7%−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%
FY10--